The Perils of Alzheimer's Drug Development

Files
Schneider2009Perils-AAM.pdf (38.4 KB)
Date
2009
Authors
Schneider, Lon S.
Lahiri, Debomoy K.
Language
American English
Embargo Lift Date
Department
Psychiatry, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Bentham Science
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract
Description
Keywords
Alzheimer disease, Drug evaluation, Physostigmine, Drug industry, Biomedical research
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Schneider LS, Lahiri DK. The perils of Alzheimer's drug development. Curr Alzheimer Res. 2009;6(1):77-78. doi:10.2174/156720509787313871
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Current Alzheimer Research
Rights
Publisher Policy
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/53504
DOI
https://doi.org/10.2174/156720509787313871
Version
Author's manuscript
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles